April 2, 2024: Harvard Surgical HSR Speaker Event

Improving Risk Communication to Optimize Shared Decision Making in Prostate Cancer 

with Timothy Daskivich, MD, MSPHM

Tuesday, April 2, 2024 @ 4-5 PM ET



This event is a hybrid webinar. 

On-site: BC-4118, 4th floor, One Brigham Circle

Online: The Zoom link will be emailed to you once registration is completed.


Upon completion of this activity, participants will be able to:

  • Understand how to optimize communication of prognosis and side effects in surgical treatment consultations
  • Understand patient preferences for risk communication
  • Understand how inadequate risk communication can lead to bias in treatment counseling


In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Timothy J. Daskivich, MD, MSHPM is an Assistant Professor and the Director of Urologic Oncology in the Department of Urology at Cedars-Sinai Medical Center. He earned his MD from Harvard Medical School in 2006, completed his residency in Urology at UCLA in 2012 and did a combined health services research and urologic oncology fellowship with the Robert Wood Johnson Clinical Scholars Program and Institute of Urologic Oncology at UCLA.

Dr. Daskivich’s clinical practice includes comprehensive management of all genitourinary malignancies, including open, laparoscopic, and robotic approaches, with a focus on single and multiport robotic surgery and focal therapy for prostate cancer. His main research interests are longevity assessment and improving risk communication to optimize shared decision making in prostate cancer. He also conducts investigator-initiated trials involving prostate PET MRI imaging and using activity monitors to assess postoperative ambulation in men undergoing major surgery. He won the AUA/Urology Care Foundation Astellas Rising Stars in Urology Research award in 2018 for his NIH/NCI-funded K08 career development award, which involved development of a patient-centered approach to improve the quality of communication of prognosis and life expectancy to patients during prostate cancer treatment counseling discussions.


This activity is intended for research faculty and trainees


Zara Cooper, MD, MSc, FACS

Michele and Howard J. Kessler Distinguished Chair of Surgery and Public Health
Kessler Director, Center for Surgery and Public Health, Brigham and Women’s Hospital
Director, Center for Geriatric Surgery, Brigham and Women’s Hospital
Professor of Surgery, Harvard Medical School

More information on this event series can be found here.